These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9644654)

  • 1. Prolongation of PT and APTT under excessive anticoagulant in plasma from rats and dogs.
    Kurata M; Noguchi N; Kasuga Y; Sugimoto T; Tanaka K; Hasegawa T
    J Toxicol Sci; 1998 May; 23(2):149-53. PubMed ID: 9644654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artifactual prolongation of the activated partial thromboplastin time associated with hemoconcentration in dogs.
    O'Brien SR; Sellers TS; Meyer DJ
    J Vet Intern Med; 1995; 9(3):169-70. PubMed ID: 7674218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of plasma for add-on PT and APTT tests.
    Neofotistos D; Oropeza M; Ts'ao CH
    Am J Clin Pathol; 1998 Jun; 109(6):758-63. PubMed ID: 9620036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing.
    Adcock DM; Kressin DC; Marlar RA
    Am J Clin Pathol; 1997 Jan; 107(1):105-10. PubMed ID: 8980376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of citrate concentration on coagulation test results in dogs.
    Stokol T; Brooks MB; Erb HN
    J Am Vet Med Assoc; 2000 Dec; 217(11):1672-7. PubMed ID: 11110458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism for shortening PT and APTT in dogs and rats--effect of fibrinogen on PT and APTT--.
    Kurata M; Sasayama Y; Yamasaki N; Kitazawa I; Hamada Y; Horii I
    J Toxicol Sci; 2003 Dec; 28(5):439-43. PubMed ID: 14746347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of sex on activated partial thromboplastin time (aPTT) and prothrombin time (PT) in sheep.
    Leite Carlos MM; Melo MM; Soto-Blanco B
    Vet Ital; 2017 Sep; 53(3):255-258. PubMed ID: 29152708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do elevated hematocrits prolong the PT/aPTT?
    Austin M; Ferrell C; Reyes M
    Clin Lab Sci; 2013; 26(2):89-94. PubMed ID: 23772474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Acute Need Inspiration: Autoneutralization of Lupus Anticoagulants in Affected Prothrombin Times (PT) and Activated Partial Thromboplastin Times (APTT).
    Gosselin RC
    Methods Mol Biol; 2023; 2663():289-295. PubMed ID: 37204718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimum specimen volume requirements for routine coagulation testing: dependence on citrate concentration.
    Adcock DM; Kressin DC; Marlar RA
    Am J Clin Pathol; 1998 May; 109(5):595-9. PubMed ID: 9576579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects.
    De Kam PJ; Grobara P; Prohn M; Höppener F; Kluft C; Burggraaf J; Langdon RB; Peeters P
    Int J Clin Pharmacol Ther; 2014 Mar; 52(3):227-36. PubMed ID: 24447651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 2 concentrations of sodium citrate on coagulation test results, von Willebrand factor concentration, and platelet function in dogs.
    Morales F; Couto CG; Iazbik MC
    J Vet Intern Med; 2007; 21(3):472-5. PubMed ID: 17552453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The danger of relying on the APTT and PT in patients on DOAC therapy, a potential patient safety issue.
    Adcock DM; Gosselin RC
    Int J Lab Hematol; 2017 May; 39 Suppl 1():37-40. PubMed ID: 28447415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of heparin V: in vivo and in vitro factors affecting the relationship between concentration and anticoagulant effect of heparin in rat plasma.
    Whitfield LR; Levy G
    J Pharm Sci; 1983 Oct; 72(10):1141-6. PubMed ID: 6644559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivaroxaban demonstrates in vitro anticoagulant effects in canine plasma.
    Conversy B; Blais MC; Dunn M; Gara-Boivin C; Carioto L; del Castillo JR
    Vet J; 2013 Nov; 198(2):437-43. PubMed ID: 24053991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective characterization of canine coagulopathies using the turbidimetric ACL-TOP 300 analyzer (2014-2015): Forty-seven dogs.
    Richardson R; Todd JM; Sharkey LC; Washabau RJ; Williams KD; Little KJ; Rendahl A
    J Vet Emerg Crit Care (San Antonio); 2018 Nov; 28(6):551-558. PubMed ID: 30320489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged prothrombin time and activated partial thromboplastin time due to underfilled specimen tubes with 109 mmol/L (3.2%) citrate anticoagulant.
    Reneke J; Etzell J; Leslie S; Ng VL; Gottfried EL
    Am J Clin Pathol; 1998 Jun; 109(6):754-7. PubMed ID: 9620035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of high-concentration calcium chloride solution for correction of activated partial thromboplastin time (APTT) in patients with high-hematocrit value.
    Kanahara M; Kai H; Okamura T; Wada T; Suda K; Imaizumi T; Sagawa K
    Thromb Res; 2008; 121(6):781-5. PubMed ID: 17904620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective evaluation of shortened prothrombin time or activated partial thromboplastin time for the diagnosis of hypercoagulability in dogs: 25 cases (2006-2011).
    Song J; Drobatz KJ; Silverstein DC
    J Vet Emerg Crit Care (San Antonio); 2016 May; 26(3):398-405. PubMed ID: 27074596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in PT and APTT When Administrating Rivaroxaban, a Direct Inhibitor of Activated Factor X].
    Nogi K; Kawasugi K; Matsuzawa M; Okufuji Y; Shimadu C; Miyazawa Y; Furukawa T
    Rinsho Byori; 2015 Feb; 63(2):194-200. PubMed ID: 26529970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.